Yiling Health Center Technology Co., Ltd. announced that it will receive CNY 70,000,000 in equity funding on December 8, 2018. The transaction will include participation from returning investor Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) to increase its stake from 91.17% to 97.79% stake in the company after the transaction. The registered capital of the company will increase from CNY 247,000,000 to CNY 317,000,000. The transaction was approved in the 18th meeting of the company’s 6th directorate held on December 7, 2018. The transaction does not require shareholder’s approval.